RUXOLITINIB News
RUXOLITINIB currently has 8 news articles, with 17 predicted indications.
This page combines the AI-predicted indications for RUXOLITINIB with the latest health news. Indications highlighted in orange have recent news coverage.
Drug Information
- Evidence level: L5
- Predicted indications (17):
- myelofibrosis (99.0%)
- primary myelofibrosis (99.0%)
- polycythemia (disease) (99.0%)
- myeloproliferative neoplasm (99.0%)
- plasmacytoma (99.0%)
- bone marrow neoplasm (99.0%)
- acquired polycythemia vera (99.0%)
- uterine corpus perivascular epithelioid cell tumor (99.7%)
- benign PEComa (99.7%)
- lymphangiomyoma (99.7%)
- lymphangioleiomyomatosis (99.6%)
- liposarcoma (99.5%)
- familial rhabdoid tumor (99.5%)
- lung PEComa (99.4%)
- ovarian myxoid liposarcoma (99.4%)
- hemophagocytic syndrome associated with an infection (99.3%)
- acquired hemophagocytic lymphohistiocytosis associated with malignant disease (99.3%)
Related News (8)
New NHS Genetic Test Can Identify Brain Tumour Type In 2 Hours During Surgery - Health and Me
2026-09-28 cancer tumour tumor
Source: Health and Me
Dr. Paterlini: Blood Test Finds Cancer Before Scans Can
2026-09-28 cancer
Source: Yahoo
Jipmer holds childhood cancer awareness programme - The Hindu
2026-09-28 cancer
Source: The Hindu
Access to cancer genetic testing unequal worldwide: New Lancet Commission - The Hindu
2026-09-28 cancer
Source: The Hindu
Targeting One Enzyme Could Stop Cancer-Linked Proteins From Escaping Destruction - Technology Networks
2026-09-28 cancer ovarian cancer
Source: Technology Networks
Lung cancer deaths down 16% with low-dose CT screening: IARC - The Times of India
2026-09-28 cancer
Source: The Times of India
Hot Drinks Tied to Esophageal Cancer. Should Patients Worry?
2026-09-22 cancer
Source: Medscape
Blood-Based Assay Shows Promise in Detection of Early Pancreatic Cancer - Cancer Therapy Advisor
2026-09-22 cancer pancreatic cancer pancreatic cancer
Source: Cancer Therapy Advisor
Disclaimer: The news on this page is collected automatically and is for research reference only; it does not constitute medical advice.